P&G chair Moeller exercises options, sells shares

Procter & Gamble executive chair Jon R. Moeller, who also serves as a director, reported option exercises and share sales in February 2026.

Rhea-AI Filing Summary

Procter & Gamble executive chair Jon R. Moeller, who also serves as a director, reported option exercises and share sales in February 2026. On February 11, he exercised options for 11,036 common shares at $113.23 and sold 11,036 shares at $160. On February 12, he exercised options for 162,232 shares at $113.23 and sold 162,232 shares at a weighted average price of $162.4486. After these transactions, he directly holds 319,384.99 common shares, plus indirect holdings of 25,001.0511 shares through retirement plan trustees and 35,421.5707 shares held by his spouse.

Insider Trade Summary

Exercise and Sale: 173,268 shares ($8.50M approx. pre-tax spread)

Exercise and Sale 8 txns

Insider Moeller Jon R

Role Exec. Chairman of the Board

Sold 173,268 shs ($28.12M)

Approx. gross sale proceeds $28.12M

Approx. exercise cost $19.62M

Approx. pre-tax spread $8.50M

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	162,232	$0.00	$0.00
Exercise	Common Stock	162,232	$113.23	$18.37M
Sale	Common Stock	162,232	$162.4486	$26.35M
Exercise	Stock Option (Right to Buy)	11,036	$0.00	$0.00
Exercise	Common Stock	11,036	$113.23	$1.25M
Sale	Common Stock	11,036	$160.00	$1.77M
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 319,384.99 shares (Direct); Common Stock — 25,001.0511 shares (Indirect, By Retirement Plan Trustees); Common Stock — 35,421.5707 shares (Indirect, By Spouse)

Footnotes (2)

1. F1. Weighted average price of the shares sold. The price range was $162.13 to $162.65. Full information regarding the number of shares sold at each separate price available upon request.
2. F2. Reflects adjustment to PST through December 31, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Jon R. Moeller report at Procter & Gamble (PG)?

Jon R. Moeller reported exercising stock options and selling the resulting Procter & Gamble shares. He exercised options for 11,036 and 162,232 shares, then sold the same amounts in open-market transactions on February 11 and 12, 2026 at prices around $160–$162 per share.

At what prices did Jon R. Moeller sell Procter & Gamble (PG) shares in February 2026?

Jon R. Moeller sold 11,036 Procter & Gamble shares at $160 on February 11, 2026. On February 12, 2026, he sold 162,232 shares at a weighted average price of $162.4486, with the filing noting an intraday price range of $162.13 to $162.65.

What option exercise prices did Jon R. Moeller use for Procter & Gamble (PG) shares?

For both transactions, Jon R. Moeller exercised stock options with an exercise price of $113.23 per share. These options, labeled as “Stock Option (Right to Buy),” converted into Procter & Gamble common stock before the corresponding open-market sales disclosed in the same Form 4.

How many Procter & Gamble (PG) shares does Jon R. Moeller own after these transactions?

After the reported February 2026 transactions, Jon R. Moeller directly owns 319,384.99 Procter & Gamble common shares. He also has indirect beneficial ownership of 25,001.0511 shares through retirement plan trustees and 35,421.5707 shares held by his spouse, as disclosed in the filing.

What indirect Procter & Gamble (PG) holdings are reported for Jon R. Moeller?

The Form 4 shows indirect holdings for Jon R. Moeller in two categories. He has 25,001.0511 Procter & Gamble common shares held by retirement plan trustees and 35,421.5707 shares held by his spouse, both listed as indirect beneficial ownership positions in the non-derivative holdings table.

What derivative securities did Jon R. Moeller exercise related to Procter & Gamble (PG)?

Jon R. Moeller exercised stock options labeled “Stock Option (Right to Buy)” with a conversion price of $113.23 per share. On February 11 and 12, 2026, these options converted into 11,036 and 162,232 Procter & Gamble common shares, respectively, before being sold in open-market transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 07:01 AM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moeller Jon R

(Last) (First) (Middle)

ONE PROCTER & GAMBLE PLAZA

(Street)

CINCINNATI OH 45202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PROCTER & GAMBLE Co [ PG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Exec. Chairman of the Board

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		M		11,036	A	$113.23	330,420.99	D
Common Stock	02/11/2026		S		11,036	D	$160	319,384.99	D
Common Stock	02/12/2026		M		162,232	A	$113.23	481,616.99	D
Common Stock	02/12/2026		S		162,232	D	$162.4486(1)	319,384.99	D
Common Stock								25,001.0511(2)	I	By Retirement Plan Trustees
Common Stock								35,421.5707	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$113.23	02/11/2026		M			11,036	02/28/2023	02/28/2030	Common Stock	11,036	$0	162,232	D
Stock Option (Right to Buy)	$113.23	02/12/2026		M			162,232	02/28/2023	02/28/2030	Common Stock	162,232	$0	0	D

Explanation of Responses:

1. Weighted average price of the shares sold. The price range was $162.13 to $162.65. Full information regarding the number of shares sold at each separate price available upon request.

2. Reflects adjustment to PST through December 31, 2025.

	/s/ Wednesday Shipp, Attorney-In-Fact for Jon R. Moeller	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.